Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Albert Luderer, Tim Hall

Premium

BioNano Genomics has elected Albert Luderer to its board of directors. He is currently CEO and director of Integrated Diagnostics, a personalized diagnostics company. Previously, he was president and CEO of BioTrove, which was acquired by Life Technologies. He has also served as CEO of therapeutics company Light Sciences, president and chief operating officer of BioMérieux, and has held senior management positions at Dianon Systems, Boehringer Mannheim, and Corning. He holds a PhD from Rutgers University.



Oxford Gene Technologies
has appointed Tim Hall as finance director, beginning in 2012. Previously, he was director of strategic planning at Medeva, chief financial officer at Celltech Pharmaceuticals, and most recently, finance director of Lombard Medical Technologies. He holds a degree in business administration from the University of Bath and qualified as an accountant with Touche Ross.
The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more